84 related articles for article (PubMed ID: 16438933)
1. Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissue-type plasminogen activator.
Galántai R; Módos K; Fidy J; Kolev K; Machovich R
Biochem Biophys Res Commun; 2006 Mar; 341(3):736-41. PubMed ID: 16438933
[TBL] [Abstract][Full Text] [Related]
2. Denatured proteins as cofactors for plasminogen activation.
Machovich R; Owen WG
Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
[TBL] [Abstract][Full Text] [Related]
3. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
Bell J; Duhon S; Doctor VM
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):229-34. PubMed ID: 12695744
[TBL] [Abstract][Full Text] [Related]
4. Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation.
Epple G; Langfeld K; Baier M; Holzhütter HG; Schleuning WD; Köttgen E; Gessner R; Praus M
Thromb Haemost; 2004 Mar; 91(3):465-72. PubMed ID: 14983221
[TBL] [Abstract][Full Text] [Related]
5. Competition between plasminogen and procathepsin B as a probe to demonstrate the in vitro activation of procathepsin B by the tissue plasminogen activator.
Dalet-Fumeron V; Boudjennah L; Pagano M
Arch Biochem Biophys; 1996 Nov; 335(2):351-7. PubMed ID: 8914932
[TBL] [Abstract][Full Text] [Related]
6. [The role of epsilon-amino groups of lysine of human serum albumin in heat-induced protein denaturation. Increased stability of glycosylated and alkylated albumin in aggregation during heating].
Stepuro NI; Iaroshevich NA; Ianchurevich AS
Mol Biol (Mosk); 1988; 22(2):466-72. PubMed ID: 3134610
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain.
Fabbro S; Seeds NW
J Neurochem; 2009 Apr; 109(2):303-15. PubMed ID: 19222708
[TBL] [Abstract][Full Text] [Related]
8. Effect of oversulfated chondroitin-6-sulfate or oversulfated fucoidan in the activation of glutamic plasminogen by tissue plasminogen activator: role of lysine and cyanogen bromide-fibrinogen.
Carranza YE; Anderson D; Doctor V
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):60-5. PubMed ID: 18180617
[TBL] [Abstract][Full Text] [Related]
9. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
Castañon MM; Gamba C; Kordich LC
Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
11. Enhanced plasminogen activation by staphylokinase in the presence of streptokinase beta/betagamma domains: plasminogen kringles play a role.
Dahiya M; Rajamohan G; Dikshit KL
FEBS Lett; 2005 Mar; 579(7):1565-72. PubMed ID: 15757642
[TBL] [Abstract][Full Text] [Related]
12. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
13. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
Sasaoka M; Wada Y; Hasumi K
J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
[TBL] [Abstract][Full Text] [Related]
14. Kinetic parameters for plasminogen activation by tissue type plasminogen activator.
Machovich R
Thromb Haemost; 1997 May; 77(5):1041-2. PubMed ID: 9184430
[No Abstract] [Full Text] [Related]
15. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
[TBL] [Abstract][Full Text] [Related]
16. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
17. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action and some properties of a tissue activator of plasminogen.
McCall DC; Kline DL
Thromb Diath Haemorrh; 1965 Sep; 14(1-2):116-26. PubMed ID: 16955970
[TBL] [Abstract][Full Text] [Related]
19. Effect of intrafollicular indomethacin injection on gonadotropin surge-induced expression of select extracellular matrix degrading enzymes and their inhibitors in bovine preovulatory follicles.
Li Q; Jimenez-Krassel F; Kobayashi Y; Ireland JJ; Smith GW
Reproduction; 2006 Mar; 131(3):533-43. PubMed ID: 16514196
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
Stillfried GE; Saunders DN; Ranson M
Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
